Editorial Note
Issue 02 is about sleep ā because you asked for it.
When we opened the poll at the end of Issue 01, "sleep optimization during weight loss" was the clear choice. The instinct is right. Sleep may be the single most overlooked variable in metabolic health ā and the evidence for how profoundly it shapes body composition, hormone balance, and long-term weight maintenance is more compelling than most people realize.
This issue covers what the research actually shows: why active weight loss disrupts sleep architecture, the cortisol loop that works against you when you're underslept, and which supplements have real clinical evidence ā and which don't. We'll also address why melatonin, despite its popularity, is the wrong tool for improving sleep quality.
ā The Kasivit Editorial Team
The finding that changes how you think about sleep and weight loss
In 2010, a controlled study at the University of Chicago put ten overweight adults on identical caloric-restriction diets. Half slept 8.5 hours per night. Half slept 5.5 hours. After two weeks, both groups lost approximately the same amount of weight total. But what they lost was radically different.
The well-rested group lost 55% of their weight as fat and 45% as lean mass. The sleep-deprived group lost only 25% as fat and 75% as lean mass ā at the same caloric deficit, over the same period. Same diet. Same weight lost. Dramatically different body composition outcomes.
Sleep deprivation also triggered a 24% increase in hunger and a 23% rise in appetite for high-calorie foods in that same group ā driven by elevated ghrelin (the hunger hormone) and suppressed leptin (the satiety hormone). The picture is consistent across the literature: you cannot optimize fat loss while chronically underslept.
Nedeltcheva AV et al. Annals of Internal Medicine, 2010. 153(7):435ā441.
Melatonin tells your brain it's nighttime. It doesn't improve how deeply you sleep or how long you stay in slow-wave sleep. Magnesium glycinate modulates GABA receptors and reduces cortisol, addressing the underlying mechanisms that actually determine sleep quality.
Read the full article āGLP-1 medications suppress appetite dramatically ā but nutritional needs don't shrink with your appetite. Six specific gaps ā including magnesium and the gut microbiome ā that semaglutide and tirzepatide create but don't address.
Read the full article āDuring sleep, the immune system releases cytokines needed to fight infection and inflammation. Chronic sleep deprivation reduces natural killer cell activity by up to 70% ā a connection most people don't appreciate until they get sick.
Read the full article āAdults randomized to magnesium supplementation for 8 weeks showed significant improvements across every measured sleep parameter compared to placebo: subjective sleep quality (PSQI score), sleep onset latency, total sleep duration, sleep efficiency, and serum melatonin levels. The magnesium group also showed reduced insomnia severity and lower early-morning cortisol ā the stress hormone that competes directly with sleep depth.
Six consecutive nights of mild sleep restriction (6 hours vs 8 hours) elevated late-evening cortisol by 37% in healthy adults. Elevated cortisol preferentially directs fat storage to visceral (abdominal) depots and simultaneously promotes muscle catabolism ā the same body composition pattern seen in chronic stress. This explains why sleep-deprived dieters disproportionately lose lean mass rather than fat, as seen in the Nedeltcheva trial above.
In patients with obesity and moderate-to-severe obstructive sleep apnea, tirzepatide reduced the apnea-hypopnea index (AHI) by 55ā63% over 52 weeks ā a reduction meaningfully greater than predicted from weight loss alone. GLP-1 receptors are expressed in brainstem regions that regulate upper airway tone, suggesting a direct neurological mechanism beyond adiposity reduction.
The cortisol-sleep-weight triangle: why the loop is self-reinforcing
Poor sleep raises cortisol. Elevated cortisol promotes visceral fat storage, drives hunger for high-carbohydrate foods, and suppresses growth hormone release ā growth hormone being the primary anabolic hormone responsible for lean mass maintenance during sleep. Less lean mass lowers resting metabolic rate. A lower metabolic rate makes subsequent weight loss harder and weight regain more likely.
Meanwhile, active caloric restriction ā particularly the rapid early weight loss common in GLP-1 therapy ā itself disrupts sleep. Reduced body fat decreases physical warmth (adipose tissue provides insulation), changes nighttime blood glucose dynamics, and alters the production of sleep-promoting hormones. Many GLP-1 users report lighter, more fragmented sleep in the early months of treatment. This is not a side effect to ignore.
Breaking the loop requires addressing both sides: improving sleep quality directly (magnesium, sleep hygiene, darkness, temperature), and reducing the cortisol load that disrupts it (stress management, adaptogens with evidence, avoiding stimulants after 2 pm).
The chelated form of magnesium with documented superior bioavailability. Magnesium glycinate modulates GABA-A receptors ā the brain's primary inhibitory pathway ā and reduces late-evening cortisol, directly supporting the mechanisms that determine sleep depth and duration. Unlike magnesium oxide (less than 4% absorption, common GI distress), the glycinate chelate is well-tolerated and fully absorbed. Bedtime dosing is supported by the clinical evidence: 300ā400 mg elemental magnesium nightly.
Shop Magnesium Glycinate ā
A multi-ingredient sleep formula designed around the evidence on sleep architecture ā not just sleep onset. VitaNight combines magnesium with complementary sleep-supporting ingredients for those seeking a more comprehensive nighttime protocol. Non-habit forming; formulated for regular use during periods of active weight loss when sleep disruption is most pronounced.
Shop VitaNight āAshwagandha root extract significantly improved sleep onset latency and total sleep duration vs. placebo. A double-blind RCT of 150 healthy adults found 300 mg twice daily reduced time to fall asleep by 35% and increased total sleep time by 12% over 8 weeks. The mechanism: cortisol reduction via HPA axis modulation. PLOS ONE, 2021.
Sleeping fewer than 6 hours per night more than doubles the risk of weight regain within 1 year of successful weight loss. A prospective cohort study of 500+ adults who had lost ā„10% body weight found sleep duration to be a stronger predictor of weight regain than physical activity or dietary adherence scores. Obesity, 2022.
Growth hormone is secreted in largest pulses during slow-wave (deep) sleep ā and sleep deprivation suppresses this release by up to 60%. Growth hormone is the primary anabolic signal for muscle preservation and fat mobilization during sleep. This is one direct mechanism by which poor sleep impairs body composition outcomes during weight loss. Journal of Clinical Endocrinology & Metabolism, 2008.
Melatonin alone does not improve sleep architecture. A systematic review of 17 RCTs found melatonin reduced sleep onset latency by a modest 7 minutes but had no significant effect on slow-wave sleep, REM proportion, or overnight cortisol ā the parameters that determine sleep quality and recovery. Melatonin signals timing; magnesium addresses depth. PLOS ONE, 2013.
Published every two weeks ā each issue distills peer-reviewed research into plain language. No hype, no sponsored content. Just the evidence, clearly explained.
- Deep dives into supplement science
- Peer-reviewed article summaries
- HIS Score Wellness Insights
- No ads. No affiliate links. Ever.
Free Ā· Every two weeks Ā· Unsubscribe anytime